We are one of the very few research based companies that have successfully combined the traditional sciences of chemistry and biology with genomics and computer science into a drug development platform.
We have developed an effective way to monitor individual responses to drug action, using a selection of 'hot-spot' SNPs, as well as non-genetic markers.
We use machine learning algorithms like artificial neural networks to stratify patients in clinical studies. Drug actions are simulated along the biochemical pathways.
We discover novel, synergistic drug combinations to overcome currently unmet medical needs.